# Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD

> **NCT05663671** · — · UNKNOWN · sponsor: **Meharry Medical College** · enrollment: 230 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Ulcerative Colitis
- Crohn Colitis
- Indeterminate Colitis

## Interventions

- **DIAGNOSTIC_TEST:** Diagnostic Test

## Key facts

- **NCT ID:** NCT05663671
- **Lead sponsor:** Meharry Medical College
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663671, "Evaluate Established Anti-DEFA5 mAbs Diagnostic Efficacy and Safety in IBD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05663671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*